Levetiracetam Evolugen

Levetiracetam, the active ingredient in Levetiracetam Evolugen, is an anticonvulsant presented as an oral tablet for oral use. It treats partial seizures, generalized tonic‑clonic seizures and myoclonic seizures in patients with epilepsy.

GNH USA supplies Levetiracetam Evolugen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is used to manage seizure disorders within the epilepsy therapeutic pathway. - Partial seizures: reduces frequency and severity of focal onset seizures. - Generalized tonic‑clonic seizures: helps control convulsive episodes across the brain. - Myoclonic seizures: diminishes rapid, involuntary muscle jerks associated with this seizure type.

Levetiracetam may cause a range of adverse reactions.

Common Side Effects: - Fatigue: feeling of tiredness or lack of energy. - Dizziness: sensation of light‑headedness or unsteadiness. - Headache: mild to moderate head pain. - Nausea: upset stomach or urge to vomit. - Irritability: increased mood swings or agitation.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Suicidal thoughts: emergence of depressive symptoms or suicidal ideation. - Stevens‑Johnson syndrome: rare but serious skin disorder. - Blood disorders: unexplained bruising or low blood cell counts. - Severe depression: marked mood changes requiring medical attention.

Before initiating therapy, consider the following safety measures. - Renal impairment: assess kidney function and adjust dose if needed. - Pregnancy: discuss potential risks with the prescriber, as safety data are limited. - Psychiatric symptoms: monitor for mood changes, depression, or aggression. - Concomitant CNS depressants: use caution as combined effects may increase sedation. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Levetiracetam may interact with other medicines; awareness of the interaction level is important.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma concentrations. - Phenobarbital: can reduce levetiracetam effectiveness. - Strong enzyme inducers: may decrease drug exposure.

Moderate Interactions (Monitor Closely): - Alcohol: additive CNS depression may increase drowsiness. - Other antiepileptics: monitor seizure control and side‑effect profile. - Renal excretion inhibitors: watch for altered drug clearance and adjust as necessary.